The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

Currently available medications could be enough to end the HIV epidemic in the United States, provided people can access and ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Now, the fight against HIV/AIDS is not just about governments and global health organisations anymore; it is a deeply personal one. And it is all about the choices you make, the conversations you have ...

This article, Part One of the Mercury’s Pulse Check series, was produced as a project for the USC Annenberg Center for Health ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV ...

According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...

HIV prevention drug Lenacapavir, which has been tested in South Africa during clinical trials, will be made available in the ...

This is from an excerpt 'The Hollywood Reporter' published from author Jeff Pearlman's 'Only God Can Judge Me: The Many Lives ...